BofA more confident in Teva Pharma after management meetings By Investing.com – Canada Boosts
© Reuters. BofA extra assured in Teva Pharma (TEVA) after administration conferences Investor sentiment on Teva Pharma’s (NYSE:) story continues to enhance, in accordance with analysts at BofA, who reiterated a Purchase ranking and $13 per share worth goal on the inventory on Monday. The analysts defined to traders in a notice that the agency…